FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

John Ormiston

Research Profile

Procedures

Devices

Concepts & Ideas

Chemicals & Drugs

Disorders

Anatomy

Coronary Vessels

Geographic Areas

Co-author Network

Publications

TOP 3
John A Ormiston; Paul L Underwood; Mark W I Webster; Louis A Cannon; O'Shaughnessy Charles; Jack J Hall; Tift Mann; Thomas McGarry; Gregory J Mishkel; Keith D Dawkins
Final 5-year results of the TAXUS ATLAS, TAXUS ATLAS Small Vessel, and TAXUS ATLAS Long Lesion clinical trials of the TAXUS Liberté paclitaxel-eluting stent in de-novo coronary artery lesions.
Roberto Diletti; Dariusz Dudek; Vasim Farooq; Hector M. Garcia; Chrysafios Girasis; Bill D Gogas; Jung Ho Heo; Jacques Koolen; Xiaolin Li; Dougal R McClean; Ian Meredith; Karine Miquel-Hebert; Yoshinobu Onuma; John A Ormiston; Evelyn Regar; Pieter Smits; Leif Thuesen; Robert Jan Van geuns; Susan Veldhof; Robert Whitbourn; Stephan Windecker; Christos V Bourantas; Bernard Chevalier; Bernard De Bruyne; Patrick Washington Serruys
Clinical and intravascular imaging outcomes at 1 and 2 years after implantation of absorb everolimus eluting bioresorbable vascular scaffolds in small vessels. Late lumen enlargement: does bioresorption matter with small vessel size? Insight from the ABSORB cohort B trial.
John A Ormiston; Richard Rapoza; Patrick Washington Serruys; Pieter C Smits; Leif Thuesen; Robert Jan Van geuns; Susan Veldhof; Robert Whitbourn; Stephan Windecker; Bernard Chevalier; Bernard de Bruyne; Cecile Dorange; Dariusz Dudek; Karine Miquel Hebert; Jacques Koolen; Dougal R McClean; Ian Meredith; Yoshinobu Onuma; Hector M. Garcia
First serial assessment at 6 months and 2 years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of John Ormiston (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: John A Ormiston; Paul L Underwood; Mark W I Webster; Louis A Cannon; O'Shaughnessy Charles; Jack J Hall; Tift Mann; Thomas McGarry; Gregory J Mishkel; Keith D Dawkins
Final 5-year results of the TAXUS ATLAS, TAXUS ATLAS Small Vessel, and TAXUS ATLAS Long Lesion clinical trials of the TAXUS Liberté paclitaxel-eluting stent in de-novo coronary artery lesions.
Coronary artery disease 2013;24(1):61-8.
2013: Roberto Diletti; Dariusz Dudek; Vasim Farooq; Hector M. Garcia; Chrysafios Girasis; Bill D Gogas; Jung Ho Heo; Jacques Koolen; Xiaolin Li; Dougal R McClean; Ian Meredith; Karine Miquel-Hebert; Yoshinobu Onuma; John A Ormiston; Evelyn Regar; Pieter Smits; Leif Thuesen; Robert Jan Van geuns; Susan Veldhof; Robert Whitbourn; Stephan Windecker; Christos V Bourantas; Bernard Chevalier; Bernard De Bruyne; Patrick Washington Serruys
Clinical and intravascular imaging outcomes at 1 and 2 years after implantation of absorb everolimus eluting bioresorbable vascular scaffolds in small vessels. Late lumen enlargement: does bioresorption matter with small vessel size? Insight from the ABSORB cohort B trial.
Heart (British Cardiac Society) 2013;99(2):98-105.
2012: John A Ormiston; Richard Rapoza; Patrick Washington Serruys; Pieter C Smits; Leif Thuesen; Robert Jan Van geuns; Susan Veldhof; Robert Whitbourn; Stephan Windecker; Bernard Chevalier; Bernard de Bruyne; Cecile Dorange; Dariusz Dudek; Karine Miquel Hebert; Jacques Koolen; Dougal R McClean; Ian Meredith; Yoshinobu Onuma; Hector M. Garcia
First serial assessment at 6 months and 2 years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study.
Circulation. Cardiovascular interventions 2012;5(5):620-32.
2012: Salvatore Brugaletta; Bernard Chevalier; Cecile Dorange; Vasim Farooq; Hector M. Garcia; Josep Gomez-Lara; Jung Ho Heo; Dougal R McClean; Ian Meredith; John A Ormiston; Richard Rapoza; Leif Thuesen; Robert Jan Van geuns; Susan Veldhof; Robert Whitbourn; Stephan Windecker; Patrick Washington Serruys
Analysis of 1 year virtual histology changes in coronary plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffold.
The international journal of cardiovascular imaging 2012;28(6):1307-14.
2012: Salvatore Brugaletta; Nico Bruining; Hector M. Garcia; Josep Gomez-Lara; Jacques Koolen; Dougal R McClean; James Oberhauser; John A Ormiston; Maria D Radu; Richard Rapoza; Leif Thuesen; Robert Jan Van geuns; Robert Whitbourn; Stephan Windecker; Patrick Washington Serruys
Head to head comparison of optical coherence tomography, intravascular ultrasound echogenicity and virtual histology for the detection of changes in polymeric struts over time: insights from the ABSORB trial.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2012;8(3):352-8.
2012: Josep Gomez-Lara; Jacques Koolen; Dougal R McClean; Yoshinobu Onuma; John A Ormiston; Richard Rapoza; Evelyn Regar; Salvatore Brugaletta; Roberto Diletti; Cecile Dorange; Dariusz Dudek; Vasim Farooq; Hector M. Garcia; Leif Thuesen; Susan Veldhof; Robert Whitbourn; Stefan Windecker; Patrick Washington Serruys
Angiographic maximal luminal diameter and appropriate deployment of the everolimus-eluting bioresorbable vascular scaffold as assessed by optical coherence tomography: an ABSORB cohort B trial sub-study.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2012;8(2):214-24.
2012: Bill D Gogas; Jung Ho Heo; Jacques Koolen; Dougal R McClean; Karine Miquel-Hebert; Yoshinobu Onuma; Salvatore Brugaletta; Bernard Chevalier; Bernard De Bruyne; Roberto Diletti; Cecile Dorange; Dariusz Dudek; Vasim Farooq; Hector M. Garcia; Maria D Radu; Richard Rapoza; Evelyn Regar; Patrick Washington Serruys; Pieter C Smits; Leif Thuesen; Robert Jan Van geuns; Robert Whitbourn; Stefan Windecker; John A Ormiston
Vascular response of the segments adjacent to the proximal and distal edges of the ABSORB everolimus-eluting bioresorbable vascular scaffold: 6-month and 1-year follow-up assessment: a virtual histology intravascular ultrasound study from the first-in-man ABSORB cohort B trial.
JACC. Cardiovascular interventions 2012;5(6):656-65.
2012: Salvatore Brugaletta; Nico Bruining; Bernard De Bruyne; Cecile Dorange; Dariusz Dudek; Vasim Farooq; Hector M. Garcia; Jung Ho Heo; Jacques Koolen; Dougal R McClean; Yoshinobu Onuma; John A Ormiston; Richard Rapoza; Pieter C Smits; Robert Jan Van geuns; Susan Veldhof; Patrick Washington Serruys
Endothelial-dependent vasomotion in a coronary segment treated by ABSORB everolimus-eluting bioresorbable vascular scaffold system is related to plaque composition at the time of bioresorption of the polymer: indirect finding of vascular reparative therapy?
European heart journal 2012;33(11):1325-33.
2012: Juan Luis Gutiérrez-Chico; Dougal R McClean; Yoshinobu Onuma; John A Ormiston; Evelyn Regar; Salvatore Brugaletta; Bernard Chevalier; Bernard De Bruyne; Dariusz Dudek; Frank Gijsen; Leif Thuesen; Jolanda Wentzel; Robert Whitbourn; Stephan Windecker; Patrick Washington Serruys
Differences in neointimal thickness between the adluminal and the abluminal sides of malapposed and side-branch struts in a polylactide bioresorbable scaffold: evidence in vivo about the abluminal healing process.
JACC. Cardiovascular interventions 2012;5(4):428-35.
2012: Salvatore Brugaletta; Bernard De Bruyne; Roberto Diletti; Dariusz Dudek; Vasim Farooq; Hector M. Garcia; Josep Gomez-Lara; John A Ormiston; Robert Jan Van geuns; Patrick Washington Serruys
Comparison of in vivo eccentricity and symmetry indices between metallic stents and bioresorbable vascular scaffolds: insights from the ABSORB and SPIRIT trials.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2012;79(2):219-28.
2012: Giovanna Sarno; Leif Thuesen; Susan Veldhof; Salvatore Brugaletta; Nico Bruining; Sebastiaan De Winter; Cecile Dorange; Dariusz Dudek; Hector M. Garcia; Scot Garg; Yoshinobu Onuma; John A Ormiston; Evelyn Regar; Patrick Washington Serruys
Morphological and functional evaluation of the bioresorption of the bioresorbable everolimus-eluting vascular scaffold using IVUS, echogenicity and vasomotion testing at two year follow-up: a patient level insight into the ABSORB A clinical trial.
The international journal of cardiovascular imaging 2012;28(1):51-8.
2011: Patrick Washington Serruys; Pieter C Smits; Krishnankutty Sudhir; Leif Thuesen; Robert Jan Van geuns; Susan Veldhof; Robert Whitbourn; Stephan Windecker; Bernard Chevalier; Bernard De Bruyne; Cecile Dorange; Dariusz Dudek; Hector M. Garcia; Karine Miquel Hebert; Jacques Koolen; Dougal R McClean; Ian Meredith; Yoshinobu Onuma; John A Ormiston
Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes.
Journal of the American College of Cardiology 2011;58(15):1578-88.
2011: John A Ormiston; Patrick Washington Serruys; Frederic De Vroey; Mark W I Webster
Bioresorbable polymeric vascular scaffolds: a cautionary tale.
Circulation. Cardiovascular interventions 2011;4(5):535-8.
2011: Dean J Kereiakes; Tift Mann; Thomas McGarry; Gregory J Mishkel; John A Ormiston; Mark A Turco; Paul Underwood; Hong Wang; Louis A Cannon; Keith D Dawkins
Propensity-matched patient-level comparison of the TAXUS Liberté and TAXUS element (ION) paclitaxel-eluting stents.
The American journal of cardiology 2011;108(6):828-37.
2011: Josep Gomez-Lara; Jacques Koolen; Dougal R McClean; Yoshinobu Onuma; John A Ormiston; Maria Radu; Richard Rapoza; Evelyn Regar; Salvatore Brugaletta; Roberto Diletti; Dariusz Dudek; Vasim Farooq; Hector M. Garcia; Pieter C Smits; Leif Thuesen; Susan Veldhof; Robert Whitbourn; Stephan Windecker; Patrick Washington Serruys
Serial analysis of the malapposed and uncovered struts of the new generation of everolimus-eluting bioresorbable scaffold with optical coherence tomography.
JACC. Cardiovascular interventions 2011;4(9):992-1001.
2011: Roberto Diletti; Dariusz Dudek; Vasim Farooq; Hector M. Garcia; Josep Gomez-Lara; Jacques Koolen; Dong Li; Dougal R McClean; Ian Meredith; Yoshinobu Onuma; John A Ormiston; Richard Rapoza; Evelyn Regar; Pieter Smits; Leif Thuesen; Robert Jan Van geuns; Susan Veldhof; Robert Whitbourn; Stephan Windecker; Salvatore Brugaletta; Bernard Chevalier; Bernard De Bruyne; Patrick Washington Serruys
6-month clinical outcomes following implantation of the bioresorbable everolimus-eluting vascular scaffold in vessels smaller or larger than 2.5 mm.
Journal of the American College of Cardiology 2011;58(3):258-64.
2011: Josep Gomez-Lara; Jacques Koolen; Dougal R McClean; Marie-angèle Morel; John A Ormiston; Richard Rapoza; Salvatore Brugaletta; Bernard Chevalier; Bernard De Bruyne; Cecile Dorange; Dariusz Dudek; Vasim Farooq; Hector M. Garcia; Pieter C Smits; Leif Thuesen; Robert Jan Van geuns; Susan Veldhof; Robert Whitbourn; Stephan Windecker; Patrick Washington Serruys
Angiographic geometric changes of the lumen arterial wall after bioresorbable vascular scaffolds and metallic platform stents at 1-year follow-up.
JACC. Cardiovascular interventions 2011;4(7):789-99.
2011: Yoshinobu Onuma; John A Ormiston; Patrick Washington Serruys; Peter Smits; Leif Thuesen; Robert Whitbourn; Stephan Windecker; Bernard Chevalier; Bernard De Bruyne; Dariusz Dudek; Hector M. Garcia; Josep Gomez; Jacques Koolen; Dougal R McClean; Ian Meredith
Comparison of in vivo acute stent recoil between the bioresorbable everolimus-eluting coronary scaffolds (revision 1.0 and 1.1) and the metallic everolimus-eluting stent.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2011;78(1):3-12.
2011: Salvatore Brugaletta; Bernard Chevalier; Roberto Diletti; Cecile Dorange; Dariusz Dudek; Hector M. Garcia; Scot Garg; Josep Gomez-Lara; Dougal R McClean; Karine Miquel-Hebert; Yoshinobu Onuma; John A Ormiston; Krishnankutty Sudhir; Leif Thuesen; Robert Jan Van geuns; Robert Whitbourn; Stephan Windecker; Patrick Washington Serruys
Temporal changes of coronary artery plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffold.
The international journal of cardiovascular imaging 2011;27(6):859-66.
2011: Chris J Ellis; Jonathan Christiansen; Colin Edwards; Malcolm E Legget; John A Ormiston; Mark Osborne; Niels Van Pelt; Helen Winch; Greg Gamble
High calcium scores in patients with a low Framingham risk of cardiovascular (CVS) disease: implications for more accurate CVS risk assessment in New Zealand.
The New Zealand medical journal 2011;124(1335):13-26.
2011: Salvatore Brugaletta; Hector M. Garcia; Roberto Diletti; Josep Gomez-Lara; Scot Garg; Yoshinobu Onuma; Eun-Seok Shin; Robert Jan Van geuns; Bernard De Bruyne; Dariusz Dudek; Leif Thuesen; Bernard Chevalier; Dougal R McClean; Stephan Windecker; Robert Whitbourn; Cecile Dorange; Susan Veldhof; Richard Rapoza; Krishnankutty Sudhir; Nico Bruining; John A Ormiston; Patrick Washington Serruys
Comparison between the first and second generation bioresorbable vascular scaffolds: a six month virtual histology study.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2011;6(9):1110-6.
2010: Patrick Washington Serruys; Yoshinobu Onuma; John A Ormiston; Bernard De Bruyne; Evelyn Regar; Dariusz Dudek; Leif Thuesen; Pieter C Smits; Bernard Chevalier; Dougal McClean; Jacques Koolen; Stephan Windecker; Robert Whitbourn; Ian Meredith; Cecile Dorange; Susan Veldhof; Karine Miquel-Hebert; Richard Rapoza; Hector M García-García
Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes.
Circulation 2010;122(22):2301-12.
2010: Josep Gomez-Lara; Hector M. Garcia; Yoshinobu Onuma; Scot Garg; Evelyn Regar; Bernard De Bruyne; Stephan Windecker; Dougal R McClean; Leif Thuesen; Dariusz Dudek; Jacques Koolen; Robert Whitbourn; Pieter C Smits; Bernard Chevalier; Cecile Dorange; Susan Veldhof; Marie-angèle Morel; Ton de Vries; John A Ormiston; Patrick Washington Serruys
A comparison of the conformability of everolimus-eluting bioresorbable vascular scaffolds to metal platform coronary stents.
JACC. Cardiovascular interventions 2010;3(11):1190-8.
2010: Jean Fajadet; William Wijns; Gert-Jan Laarman; Karl-Heinz Kuck; John A Ormiston; Stephan Baldus; Karl E Hauptmann; Maarten J Suttorp; Janusz Drzewiecki; Michael Pieper; Heinz-Peter Schultheiss; Laura Mauri
Long-term follow-up of the randomised controlled trial to evaluate the safety and efficacy of the zotarolimus-eluting driver coronary stent in de novo native coronary artery lesions: five year outcomes in the ENDEAVOR II study.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2010;6(5):562-7.
2010: Yoshinobu Onuma; Patrick Washington Serruys; John A Ormiston; Evelyn Regar; Mark Webster; Leif Thuesen; Dariusz Dudek; Susan Veldhof; Richard Rapoza
Three-year results of clinical follow-up after a bioresorbable everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB trial.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2010;6(4):447-53.
2010: Takayuki Okamura; Yoshinobu Onuma; Héctor M García-García; Evelyn Regar; Joanna J Wykrzykowska; Jacques Koolen; Leif Thuesen; Stephan Windecker; Robert Whitbourn; Dougal R McClean; John A Ormiston; Patrick Washington Serruys
3-Dimensional optical coherence tomography assessment of jailed side branches by bioresorbable vascular scaffolds: a proposal for classification.
JACC. Cardiovascular interventions 2010;3(8):836-44.
2010: Daniel H Steinberg; Gary S Mintz; Lazar Mandinov; Alan Yu; Steven G Ellis; Eberhard Grube; Keith D Dawkins; John A Ormiston; Mark A Turco; Gregg W Stone; Neil J Weissman
Long-term impact of routinely detected early and late incomplete stent apposition: an integrated intravascular ultrasound analysis of the TAXUS IV, V, and VI and TAXUS ATLAS workhorse, long lesion, and direct stent studies.
JACC. Cardiovascular interventions 2010;3(5):486-94.
2010: Giovanna Sarno; Yoshinobu Onuma; Hector M. Garcia; Scot Garg; Evelyn Regar; Leif Thuesen; Dariusz Dudek; Susan Veldhof; Cecile Dorange; John A Ormiston; Patrick Washington Serruys
IVUS radiofrequency analysis in the evaluation of the polymeric struts of the bioabsorbable everolimus-eluting device during the bioabsorption process.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2010;75(6):914-8.
2010: Nico Bruining; Sebastiaan De Winter; Jos R T C Roelandt; Evelyn Regar; iddo heller; Ron T van Domburg; Ronald Hamers; Yoshinobu Onuma; Darius Dudek; Mark W I Webster; Leif Thuesen; John A Ormiston; Wai-Fung Cheong; Karine Miquel-Hebert; Susan Veldhof; Patrick Washington Serruys
Monitoring in vivo absorption of a drug-eluting bioabsorbable stent with intravascular ultrasound-derived parameters a feasibility study.
JACC. Cardiovascular interventions 2010;3(4):449-56.
2010: Mark W I Webster; John A Ormiston
Sorting out drug-eluting stents.
Lancet 2010;375(9720):1060-2.
2010: Ian T Meredith; Stephen G Worthley; Robert Whitbourn; darren walters; Dougal McClean; John A Ormiston; Mark Horrigan; Gerard T Wilkins; Randall Hendriks; Philip Matsis; David Muller; Donald E Cutlip
Long-term clinical outcomes with the next-generation Resolute Stent System: a report of the two-year follow-up from the RESOLUTE clinical trial.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2010;5(6):692-7.
2009: Yoshinobu Onuma; John A Ormiston; Nicolo Piazza; Patrick Washington Serruys
Everolimus-eluting bioabsorbable stent--Abbot Vascular programme.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2009;5 Suppl F():F98-F102.
2009: Hiroshi Doi; Akiko Maehara; Gary S Mintz; Alan Yu; Hong Wang; Lazar Mandinov; Jeffrey J Popma; Stephen G Ellis; Eberhard Grube; Keith D Dawkins; Neil J Weissman; Mark Turco; John A Ormiston; Gregg W Stone
Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials.
JACC. Cardiovascular interventions 2009;2(12):1269-75.
2009: Ian T Meredith; John A Ormiston; Robert Whitbourn; I Patrick Kay; David Muller; Donald E Cutlip
Five-year clinical follow-up after implantation of the Endeavor zotarolimus-eluting stent: ENDEAVOR I, first-in-human study.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2009;74(7):989-95.
2009: Patrick Gladding; Harvey White; Jamie Voss; John A Ormiston; Jim Stewart; Peter N Ruygrok; Badi Bvaldivia; Ruth Baak; Catherine White; Mark Webster
Pharmacogenetic testing for clopidogrel using the rapid INFINITI analyzer: a dose-escalation study.
JACC. Cardiovascular interventions 2009;2(11):1095-101.
2009: John A Ormiston; Mark W I Webster; Robert S Schwartz; Patrick Gladding; James T Stewart; I Patrick Kay; Peter N Ruygrok; Robert Hatrick
Feasibility, safety, and efficacy of a novel polymeric pimecrolimus-eluting stent: traditional pre-clinical safety end points failed to predict 6-month clinical angiographic results.
JACC. Cardiovascular interventions 2009;2(10):1017-24.
2009: Robert I Hatrick; John A Ormiston; Peter N Ruygrok; James T Stewart; Bruce John Webber; Hector Gonzales; Mark W I Webster
Very late changes in the dilated lesion following coronary balloon angioplasty: a 17 year serial quantitative angiographic study.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2009;5(1):121-6.
2009: Thomas W Johnson; I Patrick Kay; John A Ormiston
A novel paclitaxel-eluting dedicated bifurcation stent: a case report from the first human use Taxus Petal trial.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2009;73(5):637-40.
2009: Patrick Washington Serruys; John A Ormiston; Yoshinobu Onuma; Evelyn Regar; Nieves Gonzalo; Hector M. Garcia; Koen Nieman; Nico Bruining; Cecile Dorange; Karine Miquel-Hébert; Susan Veldhof; Mark Webster; Leif Thuesen; Dariusz Dudek
A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods.
Lancet 2009;373(9667):897-910.
2009: Ehtisham Mahmud; John A Ormiston; Mark Turco; Jeffrey J Popma; Neil J Weissman; Charles D O'Shaughnessy; Tift Mann; Jack J Hall; Thomas F McGarry; Louis A Cannon; Mark W I Webster; Lazar Mandinov; Donald S Baim
TAXUS Liberté attenuates the risk of restenosis in patients with medically treated diabetes mellitus: results from the TAXUS ATLAS program.
JACC. Cardiovascular interventions 2009;2(3):240-52.
2009: Héctor M García-García; Nieves Gonzalo; Ravindra Pawar; Neville Kukreja; Dariusz Dudek; Leif Thuesen; John A Ormiston; Evelyn Regar; Patrick Washington Serruys
Assessment of the absorption process following bioabsorbable everolimus-eluting stent implantation: temporal changes in strain values and tissue composition using intravascular ultrasound radiofrequency data analysis. A substudy of the ABSORB clinical trial.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2009;4(4):443-8.
2008: Mark Turco; John A Ormiston; Jeffrey J Popma; Jack J Hall; Tift Mann; Louis A Cannon; Mark W I Webster; Gregory J Mishkel; Charles O'Shaughnessy; Thomas F McGarry; Lazar Mandinov; Keith D Dawkins; Donald S Baim
Reduced risk of restenosis in small vessels and reduced risk of myocardial infarction in long lesions with the new thin-strut TAXUS Liberté stent: 1-year results from the TAXUS ATLAS program.
JACC. Cardiovascular interventions 2008;1(6):699-709.
2008: Patrick Gladding; Mark Webster; Irene Zeng; Helen Farrell; Jim Stewart; Peter N Ruygrok; John A Ormiston; Seif El-Jack; Guy Armstrong; Patrick Kay; Douglas Scott; Arzu Gunes; Marja-Liisa Dahl
The pharmacogenetics and pharmacodynamics of clopidogrel response: an analysis from the PRINC (Plavix Response in Coronary Intervention) trial.
JACC. Cardiovascular interventions 2008;1(6):620-7.
2008: Patrick Gladding; Mark Webster; Irene Zeng; Helen Farrell; Jim Stewart; Peter N Ruygrok; John A Ormiston; Seif El-Jack; Guy Armstrong; Patrick Kay; Douglas Scott; Arzu Gunes; Marja-Liisa Dahl
The antiplatelet effect of higher loading and maintenance dose regimens of clopidogrel: the PRINC (Plavix Response in Coronary Intervention) trial.
JACC. Cardiovascular interventions 2008;1(6):612-9.
2008: Bernard Chevalier; Carlo Di Mario; Franz-Josef Neumann; Flavio Ribichini; Philip Urban; Jeffrey J Popma; Peter J Fitzgerald; Donald E Cutlip; David O Williams; John A Ormiston; Eberhard Grube; Robert Whitbourn; Lewis B Schwartz
A randomized, controlled, multicenter trial to evaluate the safety and efficacy of zotarolimus- versus paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries The ZoMaxx I trial.
JACC. Cardiovascular interventions 2008;1(5):524-32.
2008: Suwatchai Pornratanarangsi; Seif El-Jack; Mark W I Webster; Duncan McNab; James T Stewart; John A Ormiston; Peter N Ruygrok
Extraction of challenging intracoronary thrombi: multi-device strategies using guide catheters, distal vascular protection devices and aspiration catheters.
The Journal of invasive cardiology 2008;20(9):455-62.
2008: John A Ormiston; Ehtisham Mahmud; Mark Turco; Jeffrey J Popma; Neil Weissman; Louis A Cannon; Tift Mann; Michael J Lucca; Soo-Teik Lim; Jack J Hall; Dougal McClean; David Dobies; Lazar Mandinov; Donald S Baim
Direct stenting with the TAXUS Liberté drug-eluting stent: results from the Taxus Atlas Direct Stent Study.
JACC. Cardiovascular interventions 2008;1(2):150-60.
2008: Patrick Gladding; Mark Webster; John A Ormiston; Sarah Olsen; Harvey White
Antiplatelet drug nonresponsiveness.
American heart journal 2008;155(4):591-9.
2008: John A Ormiston; Patrick Washington Serruys; Evelyn Regar; Dariusz Dudek; Leif Thuesen; Mark W I Webster; Yoshinobu Onuma; Hector M. Garcia; Robert McGreevy; Susan Veldhof
A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial.
Lancet 2008;371(9616):899-907.
2007: Seif El-Jack; Pornratanarangsi Suwatchai; James T Stewart; Peter N Ruygrok; John A Ormiston; Teena West; Mark W I Webster
Distal embolization during native vessel and vein graft coronary intervention with a vascular protection device: predictors of high-risk lesions.
Journal of interventional cardiology 2007;20(6):474-80.
2007: Ian T Meredith; John A Ormiston; Robert Whitbourn; I Patrick Kay; David Muller; Jeffrey J Popma; Donald E Cutlip; Peter J Fitzgerald
Four-year clinical follow-up after implantation of the endeavor zotarolimus-eluting stent: ENDEAVOR I, the first-in-human study.
The American journal of cardiology 2007;100(8B):56M-61M.
2007: Shuzou Tanimoto; Patrick Washington Serruys; Leif Thuesen; Dariusz Dudek; Bernard De Bruyne; Bernard Chevalier; John A Ormiston
Comparison of in vivo acute stent recoil between the bioabsorbable everolimus-eluting coronary stent and the everolimus-eluting cobalt chromium coronary stent: insights from the ABSORB and SPIRIT trials.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2007;70(4):515-23.
2007: Mark W I Webster; John A Ormiston
Drug-eluting stents and late stent thrombosis.
Lancet 2007;370(9591):914-5.
2007: John A Ormiston; Mark Webster; Seif El-Jack; Duncan C McNab; Stephanie Simpson Plaumann
The AST petal dedicated bifurcation stent: first-in-human experience.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2007;70(3):335-40.
2007: John A Ormiston; Mark Webster
Absorbable coronary stents.
Lancet 2007;369(9576):1839-40.
2007: Mark Turco; John A Ormiston; Jeffrey J Popma; Lazar Mandinov; Charles O'Shaughnessy; Tift Mann; Thomas F McGarry; Chiung-Jen Wu; Charles Chan; Mark W I Webster; Jack J Hall; Gregory J Mishkel; Louis A Cannon; Donald S Baim; Joerg Koglin
Polymer-based, paclitaxel-eluting TAXUS Liberté stent in de novo lesions: the pivotal TAXUS ATLAS trial.
Journal of the American College of Cardiology 2007;49(16):1676-83.
2007: Jean Fajadet; William Wijns; Gert-Jan Laarman; Karl-Heinz Kuck; John A Ormiston; T Münzel; Jeffrey J Popma; P J Fitzgerald; R Bonan; R E Kuntz
Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions. Clinical and angiographic results of the ENDEAVOR II Trial.
Minerva cardioangiologica 2007;55(1):1-18.
2007: John A Ormiston; Mark W I Webster; Guy Armstrong
First-in-human implantation of a fully bioabsorbable drug-eluting stent: the BVS poly-L-lactic acid everolimus-eluting coronary stent.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2007;69(1):128-31.
2006: Jean Fajadet; William Wijns; Gert-Jan Laarman; Karl-Heinz Kuck; John A Ormiston; Thomas Münzel; Jeffrey J Popma; Peter J Fitzgerald; Raoul Bonan; Richard E Kuntz
Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial.
Circulation 2006;114(8):798-806.
2006: Duncan C McNab; John A Ormiston; Mark W I Webster
Bifurcation coronary lesions and the "crush" technique.
Journal of the American College of Cardiology 2006;47(12):2566-7; author reply 2567.
2006: Akiyoshi Miyazawa; Mark W I Webster; Peter J Fitzgerald; John A Ormiston
Novel stent system for bifurcation lesions: examination by intravascular ultrasound.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2006;67(6):900-3.
2006: Seif El-Jack; Suwatchai Pornratanarangsi; John A Ormiston; Mark W I Webster
Stenting coronary trifurcation lesions: is "ménage à trois" the solution?
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2006;67(3):372-6.
2006: Seif El-Jack; Peter N Ruygrok; Mark W I Webster; James T Stewart; Nigel M Bass; Guy P Armstrong; John A Ormiston; Suwatchai Pornratanarangsi
Effectiveness of manual pressure hemostasis following transfemoral coronary angiography in patients on therapeutic warfarin anticoagulation.
The American journal of cardiology 2006;97(4):485-8.
2006: John A Ormiston; Mark W I Webster; Seif El-Jack; Peter N Ruygrok; James T Stewart; Douglas Scott; Erin Currie; Monique J Panther; Bronwyn Shaw; Barbara O'Shaughnessy
Drug-eluting stents for coronary bifurcations: bench testing of provisional side-branch strategies.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2006;67(1):49-55.
2005: Alexandre Abizaid; Mariano Albertal; John A Ormiston; Hugo Londero; Peter N Ruygrok; Ana C Seixas; Fausto Feres; Luiz A Mattos; Rodolfo Staico; Roberto L Silva; Mark Webster; Jim Stewart; Francisco Paoletti; Tori Kataoka; Peter Fitzgerald; Amanda Sousa; J Eduardo Sousa
IMPACT Trial: angiographic and intravascular ultrasound observations of the first human experience with mycophenolic acid-eluting polymer stent system.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2005;66(4):491-5.
2005: Seif El-Jack; John A Ormiston; Christopher J Ellis; Mark W I Webster
So doctor...why did I have that operation?
The Journal of invasive cardiology 2005;17(10):E11-2.
2005: Peter N Ruygrok; John A Ormiston; James T Stewart; Mark W I Webster; Seif El-Jack; Stephanie Simpson-Plaumann; I Patrick Kay; Tony M Chou
Initial experience with a new femoral artery closure device following percutaneous coronary intervention with glycoprotein IIb/IIIa inhibition.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2005;66(2):185-91.
2005: Thierry Lefèvre; John A Ormiston; Giulio Guagliumi; Heinz-Peter Schultheiss; Laurent Quilliet; Bernhard Reimers; Philippe Brunel; William Wijns; H J Buettner; F Hartmann; Susan Veldhof; Karin Miquel; Xiaolu Su; Willem J van der Giessen
The Frontier stent registry: safety and feasibility of a novel dedicated stent for the treatment of bifurcation coronary artery lesions.
Journal of the American College of Cardiology 2005;46(4):592-8.
2005: Ian T Meredith; John A Ormiston; Robert Whitbourn; I Patrick Kay; David Muller; Raoul Bonan; Jeffrey J Popma; Donald E Cutlip; Peter Fitzgerald; Ross Prpic; Richard E Kuntz
First-in-human study of the Endeavor ABT-578-eluting phosphorylcholine-encapsulated stent system in de novo native coronary artery lesions: Endeavor I Trial.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2005;1(2):157-64.
2005: R Butler; Mark W I Webster; G Davies; A Kerr; N Bass; G Armstrong; J T Stewart; P Ruygrok; John A Ormiston
Spontaneous dissection of native coronary arteries.
Heart (British Cardiac Society) 2005;91(2):223-4.
2004: John A Ormiston; Erin Currie; Mark W I Webster; Patrick Kay; Peter N Ruygrok; James T Stewart; Richard C Padgett; Monique J Panther
Drug-eluting stents for coronary bifurcations: insights into the crush technique.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2004;63(3):332-6.
2004: Cheuk-Kit Wong; Christopher J K Hammett; R The; John K French; W Gao; Bruce John Webber; J M Elliott; A W Hamer; John A Ormiston; Mark W I Webster; Ralph A H Stewart; Rohan Ameratunga; Harvey D White
Lack of association between baseline plasma homocysteine concentrations and restenosis rates after a first elective percutaneous coronary intervention without stenting.
Heart (British Cardiac Society) 2004;90(11):1299-302.
2004: Patrick Washington Serruys; John A Ormiston; Georgios Sianos; J Eduardo Sousa; Eberhard Grube; Peter den Heijer; Pim de Feyter; Pawel Buszman; Albert Schömig; Jean Marco; Lech Polonski; Leif Thuesen; Andreas M Zeiher; J H Nicholas Bett; Maarten J Suttorp; Helmut D Glogar; Mark Pitney; Gerard T Wilkins; Robert Whitbourn; Susan Veldhof; Karine Miquel; Rachel Johnson; Leslie Coleman; Renu Virmani
Actinomycin-eluting stent for coronary revascularization: a randomized feasibility and safety study: the ACTION trial.
Journal of the American College of Cardiology 2004;44(7):1363-7.
2004: John A Ormiston; Erin Currie; Monique J Panther; Mark W I Webster; Barbara O'Shaughnessy
The driver stent for coronary bifurcations: a clinical case and bench testing of provisional "culotte" side-branch stenting.
The Journal of invasive cardiology 2004;16(2):1-3; quiz 4.
2004: Kengo Tanabe; Patrick Washington Serruys; Muzaffer Degertekin; Giulio Guagliumi; Eberhard Grube; Charles Chan; Thomas Munzel; Jorge Belardi; Witold Ruzyllo; Luc Bilodeau; Henning Kelbaek; John A Ormiston; Keith D Dawkins; Louis Roy; Bradley H Strauss; Clemens Disco; Joerg Koglin; Mary E Russell; Antonio Colombo
Chronic arterial responses to polymer-controlled paclitaxel-eluting stents: comparison with bare metal stents by serial intravascular ultrasound analyses: data from the randomized TAXUS-II trial.
Circulation 2004;109(2):196-200.
2003: Peter N Ruygrok; Mark W I Webster; Justin J Ardill; Charles C Chan; Koon H Mak; Ian T Meredith; James T Stewart; John A Ormiston; Sue Price
Vessel caliber and restenosis: a prospective clinical and angiographic study of NIR stent deployment in small and large coronary arteries in the same patient.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2003;59(2):165-71.
2002: John A Ormiston; Mark W I Webster; Peter N Ruygrok; Ian T Meredith; Justin P Ardill; Christopher E Buller; Donald R Ricci; Charles Chan; Gerard P Devlin; James T Stewart; Ian M Penn; Sue Price; Bruce John Webber; Teena West
Six-month angiographic and 12-month clinical follow-up of MultiLink long (25 to 35 mm) stents for long coronary narrowings in patients with angina pectoris.
The American journal of cardiology 2002;90(3):222-6.
2002: John A Ormiston; Bronwyn L Shaw; Monique J Panther; Peter N Ruygrok; Gerard P Devlin; Ralph A H Stewart; Mark W I Webster
Percutaneous coronary intervention with bivalirudin anticoagulation, immediate sheath removal, and early ambulation: a feasibility study with implications for day-stay procedures.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2002;55(3):289-93.
2002: John A Ormiston; Mark W I Webster; Peter N Ruygrok
Stent strut thickness and restenosis.
Circulation 2002;105(2):E12.
2001: Peter N Ruygrok; Mark W I Webster; Vincent de Valk; Gerrit-Anne van Es; John A Ormiston; Marie-angèle Morel; Patrick Washington Serruys
Clinical and angiographic factors associated with asymptomatic restenosis after percutaneous coronary intervention.
Circulation 2001;104(19):2289-94.
2001: John A Ormiston; B Dixon; Mark W I Webster; Peter N Ruygrok
5 French guide catheters for percutaneous coronary intervention: a feasibility study in 100 consecutive patients.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2001;52(1):45-8.
2000: Peter N Ruygrok; John A Ormiston; Barbara O'Shaughnessy
Coronary angioplasty in New Zealand 1995-1998: a report from the National Coronary Angioplasty Registry.
The New Zealand medical journal 2000;113(1117):381-4.
2000: John A Ormiston; Mark W I Webster; Peter N Ruygrok; J M Elliott; M B Simmonds; I T Meredith; Gerard P Devlin; James T Stewart; SR Dixon; S Price; Christopher J Ellis; Teena West
A randomized study of direct coronary stent delivery compared with stenting after predilatation: the NIR future trial. On behalf of the NIR Future Trial Investigators.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2000;50(4):377-81; discussion 382-3.
2000: John A Ormiston; SR Dixon; Mark W I Webster; Peter N Ruygrok; James T Stewart; I Minchington; Teena West
Stent longitudinal flexibility: a comparison of 13 stent designs before and after balloon expansion.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2000;50(1):120-4.
2000: SR Dixon; Mark W I Webster; John A Ormiston; W J Wattie; Christopher J K Hammett
Gelfoam embolization of a distal coronary artery guidewire perforation.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2000;49(2):214-7.
2000: Mark W I Webster; SR Dixon; John A Ormiston; Peter N Ruygrok; James T Stewart
Optimal stent positioning in coronary arteries: partial balloon inflation to overcome cardiac cycle-related motion of the stent/delivery system.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2000;49(1):102-4.
1999: Peter N Ruygrok; R Melkert; Marie-angèle Morel; John A Ormiston; F W Bär; F Fernandez-Avilès; Harry Suryapranata; Keith D Dawkins; C Hanet; Patrick Washington Serruys
Does angiography six months after coronary intervention influence management and outcome? Benestent II Investigators.
Journal of the American College of Cardiology 1999;34(5):1507-11.
1999: G R Rhydwen; Mark W I Webster; Peter N Ruygrok; John A Ormiston; Barbara O'Shaughnessy; James T Stewart
Preliminary experience with the V-flex plus coronary stent: immediate and one-month clinical outcome.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 1999;47(4):504-8.
1999: John A Ormiston; Mark W I Webster; Peter N Ruygrok; J T Stewart; H D White; D S Scott
Stent deformation following simulated side-branch dilatation: a comparison of five stent designs.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 1999;47(2):258-64.
1998: SR Dixon; John A Ormiston; Mark W I Webster
Long lesion length assessment.
Catheterization and cardiovascular diagnosis 1998;45(3):299-300.
1998: Patrick Washington Serruys; B van Hout; Hans J R M Bonnier; Victor Legrand; E Garcia; Carlos Macaya; Eduardo Sousa; Willem J van der Giessen; Antonio Colombo; R Seabra-Gomes; F Kiemeneij; P Ruygrok; John A Ormiston; H Emanuelsson; Jean Fajadet; M Haude; S Klugmann; Marie-angèle Morel
Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II)
Lancet 1998;352(9129):673-81.
1998: Christopher J Ellis; John K French; Harvey D White; John A Ormiston; R M L Whitlock; Mark W I Webster
Results of percutaneous coronary angioplasty in patients <40 years of age.
The American journal of cardiology 1998;82(2):135-9.
1998: Peter N Ruygrok; G Barron; John A Ormiston; I Meredith; Mark Webster; R Harper; A Saltups; B O'Shaughnessy; J Stewart
Introduction of the Multilink stent into routine angioplasty practice: early angiographic and clinical outcome.
Catheterization and cardiovascular diagnosis 1998;43(2):147-52.
1997: John A Ormiston; F M Stewart; A H Roche; Bruce John Webber; R M L Whitlock; Mark W I Webster
Late regression of the dilated site after coronary angioplasty: a 5-year quantitative angiographic study.
Circulation 1997;96(2):468-74.
1996: G F Porter; John A Ormiston; Mark W I Webster
Percutaneous rotational coronary atherectomy: initial Green Lane and Mercy hospitals' experience.
The New Zealand medical journal 1996;109(1023):203-5.
1995: John A Ormiston; Mark W I Webster
Simultaneous inflation of tandem (sequential) angioplasty balloons: a means of simultaneously treating multiple lesions in one coronary artery.
Catheterization and cardiovascular diagnosis 1995;34(4):365-7.
1995: Harvey D White; D B Cross; Barbara F Williams; R M Norris; K S Woo; A W Hamer; J M Elliott; John A Ormiston
"Rescue" thrombolysis with intracoronary tissue plasminogen activator for failed intravenous thrombolysis with streptokinase for acute myocardial infarction.
The American journal of cardiology 1995;75(2):172-4.
1995: Harvey D White; John K French; A W Hamer; M A Brown; Barbara F Williams; John A Ormiston; D B Cross
Frequent reocclusion of patent infarct-related arteries between 4 weeks and 1 year: effects of antiplatelet therapy.
Journal of the American College of Cardiology 1995;25(1):218-23.
1993: John A Ormiston; JM Neutze; A L Calder; N S Hak
Percutaneous balloon angioplasty for early postoperative modified Blalock-Taussig shunt failure.
Catheterization and cardiovascular diagnosis 1993;29(1):31-4.
1992: John A Ormiston; A H Roche; Mark W I Webster
Directional coronary atherectomy in lesions unfavourable for balloon angioplasty: initial Green Lane and Mercy Hospitals experience.
The New Zealand medical journal 1992;105(943):391-3.
1989: W M Jaffe; H Arthur Coverdale; A H Roche; P W Brandt; John A Ormiston; B G Barratt-Boyes
Doppler echocardiography in the assessment of the homograft aortic valve.
The American journal of cardiology 1989;63(20):1466-70.
1989: Harvey D White; J T Rivers; A H Maslowski; John A Ormiston; M Takayama; H H Hart; D N Sharpe; R M L Whitlock; R M Norris
Effect of intravenous streptokinase as compared with that of tissue plasminogen activator on left ventricular function after first myocardial infarction.
The New England journal of medicine 1989;320(13):817-21.
1988: W M Jaffe; A H Roche; H Arthur Coverdale; H F McAlister; John A Ormiston; E R Greene
Clinical evaluation versus Doppler echocardiography in the quantitative assessment of valvular heart disease.
Circulation 1988;78(2):267-75.
1987: Harvey D White; R M Norris; M A Brown; M Takayama; A Maslowski; N M Bass; John A Ormiston; T Whitlock
Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction.
The New England journal of medicine 1987;317(14):850-5.
1981: John A Ormiston; JM Neutze; TM Agnew; J B Lowe; Alan R Kerr
Infective endocarditis: a lethal disease.
Australian and New Zealand journal of medicine 1981;11(6):620-9.